Losing one to two pounds per week is a reasonable and safe rate that helps you keep the weight off and gives you time to make new healthy lifestyle changes
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial PMID: 37385280 Lancet
IGF-1 possesses both, GH-like actions and insulin-like actions, whose effects in vivo depend on the dosage, length of treatment, and even route of administration [134, 135]
Food and Drug Administration for treating injuries or medical conditions, and evidence from large, well-designed human clinical trials remains limited
Cell 188 , 20432062 (2025)
In such cases, immediate medical attention is essential